T. L. Loo
Impact in
-
- Glioma Diagnosis and Treatment
-
- Metal complexes synthesis and properties
- Drug Transport and Resistance Mechanisms
Papers in
- Pharmacology 12
- Pharmacogenetics and Drug Metabolism 11
-
- Bioactive Compounds and Antitumor Agents 5
- Co-authors
- M. Daniel Lane (1 shared paper)Margaret G. Kelly (1 shared paper)David P. Rall (1 shared paper)Mario Armando Luna (4 shared papers)Benjamin Drewinko (2 shared papers)Jeffrey A. Gottlieb (2 shared papers)DavidJ. Stewart (4 shared papers)E. J. Freireich (2 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (7 papers)Experimental Biology and Medicine (3 papers)Journal of Neuro-Oncology (2 papers)Life Sciences (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United States
In The Last Decade
T. L. Loo
26 papers receiving 473 citations
Peers
Comparison fields: 5 of 76
- Genetics 59
- Oncology 137
- Toxicology 26
- Pharmacology 44
- Neurology 22
Countries citing papers authored by T. L. Loo
This map shows the geographic impact of T. L. Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. L. Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. L. Loo more than expected).
Fields of papers citing papers by T. L. Loo
This network shows the impact of papers produced by T. L. Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. L. Loo. The network helps show where T. L. Loo may publish in the future.
Co-authors
The 25 scholars most cited alongside T. L. Loo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1957 | 121 | |
| 2 | 1982 | 113 | |
| 3 | Combination chemotherapy in vitro with adriamycin. Observations of additive, antagonistic, and synergistic effects when used in two-drug combinations on cultured human lymphoma cells. | 1976 | 111 |
| 4 | 1983 | 55 | |
| 5 | 1952 | 16 | |
| 6 | A comparison of the lethal effects of three nitrosourea derivatives on cultured human lymphoma cells. | 1976 | 16 |
| 7 | 1988 | 15 | |
| 8 | Phase I clinical study of N-(phosphonacetyl)-L-aspartic acid (PALA). | 1980 | 13 |
| 9 | 1967 | 11 | |
| 10 | 1978 | 11 | |
| 11 | 1981 | 10 | |
| 12 | 1992 | 10 | |
| 13 | 1984 | 9 | |
| 14 | 1980 | 8 | |
| 15 | 1963 | 6 | |
| 16 | 1982 | 5 | |
| 17 | 1962 | 4 | |
| 18 | Liver disease and clinical pharmacology of Baker's antifolate (BAF, NSC 139105) | 1975 | 4 |
| 19 | Pharmacokinetics and metabolism of ftorafur (FT) in man | 1976 | 3 |
| 20 | 1978 | 3 |
About T. L. Loo
T. L. Loo is a scholar working on Pharmacology, Toxicology, Molecular Biology, Oncology and Genetics, having authored 26 papers that have together received 556 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (11 papers), Pharmacogenetics and Drug Metabolism (11 papers), Bioactive Compounds and Antitumor Agents (5 papers), Biochemical and Molecular Research (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Folate and B Vitamins Research (2 papers), Analytical Methods in Pharmaceuticals (2 papers) and Glioma Diagnosis and Treatment (2 papers). The work is most often cited by research in Genetics (59 citations), Oncology (137 citations), Toxicology (26 citations), Pharmacology (44 citations) and Neurology (22 citations). T. L. Loo has collaborated with scholars based in United States. Frequent co-authors include M. Daniel Lane, Margaret G. Kelly, David P. Rall, Mario Armando Luna, Benjamin Drewinko, Jeffrey A. Gottlieb, DavidJ. Stewart, E. J. Freireich, Lynn G. Feun and Katherine Lu. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Experimental Biology and Medicine, Journal of Neuro-Oncology, Life Sciences and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.